This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Hypertension. 2003;41:862.)
© 2003 American Heart Association, Inc.

Awards

Irvine Page–Alva Bradley Lifetime Achievement Award 2002

An extract of the first 250 words of the full text is provided, because this article has no abstract.

For combating hypertension through exemplary research, education, and service, Suzanne Oparil, MD, has been awarded the 2002 Irvine Page–Alva Bradley Lifetime Achievement Award. The sponsorship of this award by Monarch Pharmaceuticals is greatly appreciated.

View larger version (116K): [in this window] [in a new window]

Dr Suzanne Oparil is professor of medicine and physiology and biophysics and director of the Vascular Biology and Hypertension Program of the Division of Cardiovascular Diseases at the University of Alabama at Birmingham (UAB). She is a graduate of Cornell University and the Columbia University College of Physicians and Surgeons and received clinical training in internal medicine at Presbyterian Hospital in New York City and research training in cardiology at the Massachusetts General Hospital under the direction of the late Dr Edgar Haber. While a cardiology fellow, she developed an interest in hypertension. She has made major contributions to our understanding of the regulation of the renin-angiotensin system, neural control of blood pressure, the pathogenesis of salt-sensitive hypertension, and the effects of ovarian hormones on blood vessels and on vascular responses to injury.

Dr Oparil has been active in a leadership and policy-making role in a number of professional and voluntary health organizations. She served as president of the American Federation of Clinical (now Medical) Research, the largest clinical research organization in the world. She had previously served as chairman of the Public Policy Committee of that organization, where she formulated science policy positions that affect biomedical research at the national level. Dr Oparil is also a member of the American Society of Clinical Investigation, having . . . [Full Text of this Article]